Kidswell Bio Corporation (4584.T)
JPY 137.0
(0.74%)
JPY 137.0
(0.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.83 Billion JPY | 16.7% |
| 2022 | 1.57 Billion JPY | 152.0% |
| 2021 | 625 Million JPY | -43.18% |
| 2020 | 1.1 Billion JPY | -8.33% |
| 2019 | 1.2 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.67 Billion JPY | -8.94% |
| 2023 Q1 | 1.47 Billion JPY | -6.35% |
| 2023 Q4 | 1.83 Billion JPY | 6.55% |
| 2023 Q3 | 1.72 Billion JPY | 27.78% |
| 2023 Q2 | 1.35 Billion JPY | -8.47% |
| 2023 FY | 1.83 Billion JPY | 16.7% |
| 2022 Q2 | 1.87 Billion JPY | 0.0% |
| 2022 FY | 1.57 Billion JPY | 152.0% |
| 2022 Q4 | 1.57 Billion JPY | -5.97% |
| 2022 Q3 | 1.67 Billion JPY | -10.67% |
| 2021 FY | 625 Million JPY | -43.18% |
| 2020 FY | 1.1 Billion JPY | -8.33% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -139.619% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 8.102% |
| Linical Co., Ltd. | 1.49 Billion JPY | -22.535% |
| Trans Genic Inc. | 1.32 Billion JPY | -38.497% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -235234.187% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 21.692% |
| AnGes, Inc. | 214.94 Million JPY | -755.068% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -1620.147% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 97.093% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -2073.532% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -65.744% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -6371.234% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | -109.909% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -4606.684% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| PeptiDream Inc. | 19.63 Billion JPY | 90.639% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -1040.881% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -362.962% |
| Healios K.K. | 450 Million JPY | -308.436% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -2277.974% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | -137.68% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | -133.244% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -274.063% |
| StemCell Institute Inc. | 6.67 Million JPY | -27430.857% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -1178.581% |